HPC
QDEL icon

HM Payson & Co’s QuidelOrtho QDEL Stock Holding History

HM Payson & Co’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-65
Closed -$2.27K – 1040
2025
Q1 		$2.27K Hold
65
– – ﹤0.01% 957
2024
Q4 		$2.9K Hold
65
– – ﹤0.01% 936
2024
Q3 		$2.96K Buy
+65
New +$2.63K ﹤0.01% 937

Other funds holding QDEL

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

HM Payson & Co's QDEL Position: Q2 2025 in Review

HM Payson & Co sold out of QuidelOrtho (QDEL) in Q2 2025, closing a stake of 65 shares — an estimated $2.27K sold.

HM Payson & Co first reported a position in QDEL in Q3 2024 and held it in 3 quarters. The position peaked at $2.96K in Q3 2024. 263 funds tracked by Wall St. Rank hold QDEL as of Q2 2025.

  • HM Payson & Co reported no remaining QuidelOrtho position as of Q2 2025 after selling out during the quarter.
  • HM Payson & Co sold 65 QuidelOrtho shares in Q2 2025, an estimated $2.27K.
  • HM Payson & Co first reported a position in QuidelOrtho in Q3 2024 and held it in 3 quarters.
  • HM Payson & Co's QuidelOrtho position peaked at $2.96K in Q3 2024.
  • 263 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2025.

Based on HM Payson & Co's 13F filing for Q2 2025, filed 17 Oct 2025.